)
Gilead Sciences (GILD) investor relations material
Gilead Sciences AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting called to order by the Chairman and CEO, with introductions of board members, executive team, and independent auditor present.
Formal business conducted as per proxy statement, with procedures and technical support outlined for virtual participation.
Inspector of Election appointed and sworn in to oversee voting.
Quorum established with proxies for 91.1% of outstanding shares.
Board and executive committee updates
Nine director nominees, all current directors, were up for election for the next year.
Board recommended in favor of all director nominees and key proposals, except for certain shareholder proposals.
Shareholder proposals
Proposal for an independent board chair policy presented, citing improved governance and long-term performance; board opposed.
Proposal for a report on the impact of extended patent exclusivities on patient access discussed, highlighting reputational and financial risks; board opposed.
Proposal for a report on risks of ESG and DEI executive compensation metrics presented, emphasizing focus on fiduciary duty and minimizing political influence; board opposed.
- HIV and oncology pipelines, strong margins, and disciplined returns drive long-term growth.GILD
44th Annual J.P. Morgan Healthcare Conference13 Apr 2026 - Three major acquisitions expand pipeline and innovation in oncology, inflammation, and virology.GILD
M&A announcement7 Apr 2026 - Record sales, pipeline advances, and strong governance drive sustainable value and innovation.GILD
Proxy filing20 Mar 2026 - Annual meeting to vote on directors, auditor, compensation, and key stockholder proposals.GILD
Proxy filing20 Mar 2026 - Major launches, pipeline growth, and strategic deals drive robust outlook and diversification.GILD
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Long-acting HIV, expanded liver therapies, and cell therapy innovation drive future growth.GILD
Leerink Global Healthcare Conference 202610 Mar 2026 - 2026 growth driven by HIV, PrEP, oncology launches, and expanding inflammation pipeline.GILD
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - 2025 HIV and liver sales up 6%, EPS up 77%; 2026 outlook strong despite policy headwinds.GILD
Q4 202510 Feb 2026 - Imminent HIV PrEP launch, oncology breakthroughs, and next-gen cell therapies drive future growth.GILD
Jefferies Global Healthcare Conference 20253 Feb 2026
Next Gilead Sciences earnings date
Next Gilead Sciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage